SEC Form 4 · accession 0001493152-26-035271

Biofrontera Inc. · BFRI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Jul 28, 2026

Accepted (ET)

Jul 29, 2026 · 5:44 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001858685

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jul 28, 2026	M	31,250	—	A	206,250	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F3,F1,F2	—	Jul 28, 2026	M	31,250	D	—	—	Common Stock	31,250	31,250	D

F1Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis.
F2On July 22, 2025, the Reporting Person was granted 62,500 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
F3Restricted stock units with different terms are not included.